New weekly shot for weight loss enters human testing
NCT ID NCT07022977
Summary
This study is testing a new drug called MET233, given as a weekly injection, to see if it is safe and helps with weight loss in adults who are overweight or have obesity. Researchers will give the drug to healthy volunteers at different doses to check for side effects and measure how much weight they lose. The goal is to gather information to see if the drug works well enough to test in larger future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MET233 Research Site 001
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.